Patents by Inventor Michel Friesenhahn

Michel Friesenhahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING ALZHEIMER'S DISEASE
    Publication number: 20220195020
    Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from mild to moderate AD, including ApoE4 positive patients and patients suffering from mild AD are provided.
    Type: Application
    Filed: August 4, 2021
    Publication date: June 23, 2022
    Applicant: GENENTECH, INC.
    Inventors: William Cho, Michel Friesenhahn, Robert Paul, Michael Ward
  • METHODS OF TREATING ALZHEIMER'S DISEASE
    Publication number: 20200399352
    Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from mild to moderate AD, including ApoE4 positive patients and patients suffering from mild AD are provided.
    Type: Application
    Filed: February 5, 2020
    Publication date: December 24, 2020
    Applicant: GENENTECH, INC.
    Inventors: William Cho, Michel Friesenhahn, Robert Paul, Michael Ward
  • METHODS OF TREATING ALZHEIMER'S DISEASE
    Publication number: 20150246963
    Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from mild to moderate AD, including ApoE4 positive patients and patients suffering from mild AD are provided.
    Type: Application
    Filed: February 6, 2015
    Publication date: September 3, 2015
    Applicant: GENENTECH, INC.
    Inventors: William Cho, Michel Friesenhahn, Robert Paul, Michael Ward
  • Heteropolynucleotide duplexes with purine—purine base pairing
    Patent number: 8399194
    Abstract: The present invention relates to stable anti-parallel heteropolynucleotide duplexes, comprising a plurality of complementary purine-purine nucleobase dyads, wherein the nucleobase is coupled to a pentose sugar backbone. The present invention further relates to methods of hybridizing two heteropolynucleotide molecules to form such purine-purine nucleobase dyads, as well as kits and solid supports comprising such purine-purine nucleobase dyads.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: March 19, 2013
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Maria Albalos, Thomas Battersby, Edward Brooks, Michel Friesenhahn
  • Heteropolynucleotide Duplexes With Purine-Purine Base Pairing
    Publication number: 20100190972
    Abstract: The present invention relates to stable anti-parallel heteropolynucleotide duplexes, comprising a plurality of complementary purine-purine nucleobase dyads, wherein the nucleobase is coupled to a pentose sugar backbone. The present invention further relates to methods of hybridizing two heteropolynucleotide molecules to form such purine-purine nucleobase dyads, as well as kits and solid supports comprising such purine-purine nucleobase dyads.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 29, 2010
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Thomas Battersby, Maria Albalos, Michel Friesenhahn, Edward Brooks